Male fertility decline: what the published data shows

The trend is real, the drivers are mixed, and the conversation belongs in primary care.

TL;DR

• Global mean sperm concentration has fallen roughly in half between 1973 and 2018, with a steeper drop after 2000.
• About 1 in 6 adults worldwide experience infertility at some point — in roughly half of those couples, a male factor contributes.
• The drivers are mixed: metabolic disease, environmental exposures, and lifestyle patterns. No single cause explains it.

What it is

"Male fertility decline" refers to falling average measures of sperm quantity and quality across decades. The most-cited evidence is a 2022 meta-analysis covering 53 countries and 57,000+ men. It reports mean sperm concentration falling from about 101 million per milliliter in 1973 to about 49 million in 2018 (Levine et al., 2022). That is roughly a 51% drop.

How it works

Think of sperm production as a factory with three things to keep running: hormones, raw materials, and a cool, stable environment. Testosterone and FSH (follicle-stimulating hormone — the signal that drives sperm production) are the foreman. Metabolic health, sleep, and protein are the supply chain. Heat, alcohol, and certain medications are the disruptors. When several inputs degrade at once, output falls. That is the pattern researchers describe when they look at population-level trends.

Who asks about it

People come to this topic in two places. Couples who have been trying without success. And men in their thirties and forties reading headlines about sperm counts and wondering if it applies to them. Many are surprised that fertility is rarely tested unless something is already wrong. A semen analysis is cheap, fast, and informative — but it is not part of any standard adult wellness check.

What the research says

The Levine meta-analysis is the most-cited but not the only source. The WHO estimates about 1 in 6 adults experience infertility at some point in life, and male factors contribute in about half of evaluated couples (WHO, 2023). Smaller cohort studies link lower counts to higher body-mass index, untreated insulin resistance, certain endocrine-disrupting chemicals, and chronic heat exposure. The decline is not uniform — it is steeper in some regions and birth cohorts than others.

What to know before considering it

A standard semen analysis is the starting point. It measures count, motility, and morphology. Pair it with a hormone panel and a metabolic marker like fasting glucose and insulin. Any peptide or hormone protocol that affects fertility — including testosterone — requires a clinician evaluation, baseline labs, and ongoing follow-up. Some interventions are reversible; some are not.

The Halftime POV

The data is real. The framing matters more. Male fertility is a window onto metabolic and hormonal health, not just a reproductive question. If the window is foggy, look at what is behind it.

Related reading:

• Sermorelin, CJC-1295, ipamorelin, MK-677: a plain-language comparison
• HOMA-IR: the insulin-resistance marker your doctor might not be running
• What are peptides? A plain-English primer

---

FAQ

Q: Are sperm counts actually dropping? A: Yes. The most-cited meta-analysis (Levine et al., 2022) reports a roughly 51% decline in mean sperm concentration between 1973 and 2018, with a steeper drop after 2000.

Q: What's driving the decline? A: Researchers point to a mix of metabolic disease, obesity, environmental endocrine disruptors, sedentary patterns, and possibly heat exposure and microplastics. No single cause explains all of it.

Q: Does low sperm count always mean infertility? A: No. Sperm count is one of several measures (count, motility, morphology, DNA fragmentation). A man can have lower-than-average count and still conceive without help.

Q: What can be measured to assess male fertility? A: A standard semen analysis plus hormone panel (testosterone, LH, FSH, prolactin, estradiol, SHBG) covers the basics. Lifestyle and metabolic markers like HOMA-IR add context.

---

Disclaimer

This article is educational and is not medical advice. Compounded medications are not FDA-approved. Clinical outcomes depend on individual factors and require physician evaluation. Results vary. Halftime Health is launching soon — join the waitlist to get updates.

Get updates

Halftime Health is launching soon. We'll share what we learn along the way — the research, the regulations, the real-world trade-offs. Join the waitlist and we'll email you when we're live.

---

Sources

• Levine H et al., "Temporal trends in sperm count: a systematic review and meta-regression analysis of samples collected globally in the 20th and 21st centuries," Hum Reprod Update (2022)
• WHO, "1 in 6 people globally affected by infertility" (April 2023)

---

This article discusses compounds that are currently under FDA Category 2 review (see our FDA categorization explainer). These compounds are not currently part of Halftime Health's published protocol catalog. This article is provided for educational purposes only and does not constitute medical advice or an offer to sell.